| | |
| Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off. |
|
| | | By Drug Delivery Leader: Supplier Horizons | In this episode of Supplier Horizons, host Tom von Gunden discusses with CEO Stella Vnook from platform technology developer Likarda methods for deploying hydrogel microencapsulation to safely route cells, proteins, and other biologic agents to therapeutic targets. | |
|
| CMC For Long-Acting Injectables For TB | By Susan Ciotti, Ph.D., Gates Medical Research Institute (Gates MRI) | Long-acting injectables are a potential treatment alternative for tuberculosis, but they require key development considerations from a chemistry, manufacturing, and controls perspective. |
|
| | | | Prioritizing Finished Goods To Ensure Therapy Delivery Safety | Article | By Lenette Simonsen, Behrouz Seifi, and Morten Lahrmann, FUJIFILM Biotechnologies | As demand forecasts evolve, opt to work with a CDMO that can pivot manufacturing strategies seamlessly while accommodating your end-to-end needs, from drug substance to finished goods. |
|
| | | | | | | | |
|
|
.png){kind=logo}
